Effects of repeated treatment with a delta opioid receptor agonist KNT-127 on hyperemotionality in olfactory-bulbectomized rats.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Behavioural Brain Research

• Publication date

  2017-04-14

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.bbr.2016.11.008PMID 27916688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of 4-hydroxyisoleucine from Fenugreek Seeds on Depression-like Behavior in Socially Isolated Olfactory Bulbectomized Rats

  2015cited by this paper
• Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis.

  2015cited by this paper
• In vivo properties of KNT‐127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice

  2014cited by this paper
• The novel δ opioid receptor agonist KNT-127 produces distinct anxiolytic-like effects in rats without producing the adverse effects associated with benzodiazepines.

  2013cited by this paper
• Delta opioid receptors in brain function and diseases.

  2013cited by this paper
• Effect of newly synthesized 1,2,4-triazino[5,6-b]indole-3-thione derivatives on olfactory bulbectomy induced depression in rats.

  2012cited by this paper
• Effect of three types of mixed anesthetic agents alternate to ketamine in mice.

  2011cited by this paper
• Riluzole rapidly attenuates hyperemotional responses in olfactory bulbectomized rats, an animal model of depression.

  2011cited by this paper
• The delta opioid receptor: an evolving target for the treatment of brain disorders.

  2011cited by this paper
• The novel δ opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions.

  2011cited by this paper
• Design and synthesis of KNT-127, a δ-opioid receptor agonist effective by systemic administration.

  2010cited by this paper
• Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants.

  2008cited by this paper
• Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.

  2008cited by this paper
• Effects of milnacipran and fluvoxamine on hyperemotional behaviors and the loss of tryptophan hydroxylase-positive cells in olfactory bulbectomized rats

  2007cited by this paper
• The antidepressant -like effects of delta-opioid receptor agonists.

  2006cited by this paper
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• The olfactory bulbectomised rat as a model of depression.

  2005cited by this paper
• Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents.

  2004cited by this paper
• The olfactory bulbectomized rat as a model of depression: an update.

  1997cited by this paper
• Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys.

  1994cited by this paper
• Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.

  1993cited by this paper
• Epidemiology of panic disorder: progress and unresolved issues.

  1993cited by this paper
• Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats.

  1990cited by this paper
• Send Orders of Reprints at Reprints@benthamscience.org Antidepressant-like Effects of Δ Opioid Receptor Agonists in Animal Models

  year unknowncited by this paper

• Rapid‐Onset Therapeutic Effects of Delta Opioid Receptor Agonists on Depression‐Like Behaviors Induced by Chronic Social Defeat Stress

  2025cites this paper
• Inaudible airborne ultrasound affects emotional states in the olfactory bulbectomized rat depression model

  2025cites this paper
• Laser‐Induced Olfactory Bulbectomy in Adult Zebrafish as a Novel Putative Model for Affective Syndrome: A Research Tribute to Brian Leonard

  2025cites this paper
• [Underlying mechanisms for psychotropic effects of delta opioid receptor agonists].

  2024cites this paper
• SYK-623, a δ Opioid Receptor Inverse Agonist, Mitigates Chronic Stress-Induced Behavioral Abnormalities and Disrupted Neurogenesis

  2024cites this paper
• Agonists of the opioid δ‐receptor improve irritable bowel syndrome‐like symptoms via the central nervous system

  2024cites this paper
• Delta opioid receptor agonists activate PI3K–mTORC1 signaling in parvalbumin-positive interneurons in mouse infralimbic prefrontal cortex to exert acute antidepressant-like effects

  2024cites this paper
• KNT-127, a selective delta opioid receptor agonist, shows beneficial effects in the hippocampal dentate gyrus of a chronic vicarious social defeat stress mouse model.

  2023cites this paper
• [Neural mechanism underlying the regulation of emotional behavior via δ-opioid receptors].

  2022cites this paper
• Antidepressant Effect of Intracerebroventricularly Administered Deltorphin Analogs in the Mouse Tail Suspension Test.

  2022cites this paper
• High-frequency ultrasound exposure improves depressive-like behavior in an olfactory bulbectomized rat model of depression

  2022cites this paper
• To probe the activation mechanism of the Delta opioid receptor by an agonist ADL5859 started from inactive conformation using molecular dynamic simulations

  2022cites this paper
• Modulation of glutamatergic synaptic transmission and neuronal excitability in the prelimbic medial prefrontal cortex via delta-opioid receptors in mice.

  2021cites this paper
• A non‐convulsant delta‐opioid receptor agonist, KNT‐127, reduces cortical spreading depression and nitroglycerin‐induced allodynia

  2020cites this paper
• Urinary metabolic disturbance in the olfactory bulbectomized rats and the modulatory effects of fluoxetine.

  2019cites this paper
• Endogenous Opiates and Behavior: 2017.

  2019cites this paper
• Research and development of κ opioid receptor agonists and δ opioid receptor agonists.

  2019cites this paper
• Hippocampus Metabolic Disturbance and Autophagy Deficiency in Olfactory Bulbectomized Rats and the Modulatory Effect of Fluoxetine

  2019cites this paper
• Delta Opioid Receptors and Modulation of Mood and Emotion.

  2018cites this paper
• OBscure but not OBsolete: Perturbations of the frontal cortex in common between rodent olfactory bulbectomy model and major depression.

  2018cites this paper
• Post‐reexposure administration of riluzole attenuates the reconsolidation of conditioned fear memory in rats

  2018influential citation
• Modulation of the central opioid system as an antidepressant target in rodent models.

  2018cites this paper
• Kappa Opioid Receptor Agonist Administration in Olfactory Bulbectomized Mice Restores Cognitive Impairment through Cholinergic Neuron Activation.

  2018cites this paper